Stock Rating Upgrade Reflecting improving fundamentals and high Appreciation Potential, the Value Trend Rating for Zumiez Inc (NASDAQ: ZUMZ) improved of late. ZUMZ’s current Value Trend Rating is C and the prior Rating was D. […]
Semler Scientific Inc (NASDAQ: SMLR) stock closed at $32.04 on 11/10/23 after a major increase of 10.0%. Relative to the market the stock has been exceptionally strong over the last nine months and has risen […]
Stock Rating Downgrade Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for Microsoft Corp (NASDAQ: MSFT) weakened in recent days. MSFT’s current Value Trend Rating is C and the prior Rating was […]
Stock Rating Downgrade In the last week the Value Trend Rating for Innoviva Inc (NASDAQ: INVA) weakened from B to C reflecting eroding fundamentals and low Appreciation Potential. Recent Price Action On 11/10/23, Innoviva Inc […]
Stock Rating Upgrade Of late the Value Trend Rating for CVS Health Corp (NYSE: CVS) improved from C to B reflecting improving fundamentals and high Appreciation Potential. Recent Price Action On 11/10/23, CVS Health Corp […]
Stock Rating Downgrade The Value Trend Rating for inTest Corp (NYSEAMERICAN: INTT) fell significantly of late from C to F reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in […]
Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) stock closed at $52.41 on 11/9/23 after a major increase of 15.4%. The stock has been exceptionally strong relative to the market over the last nine months and has risen […]
Notable negative changes in Valero Energy Corp (NYSE: VLO) fundamentals have recently occurred: significant quarterly sales deceleration occurred, significant quarterly earnings deceleration occurred, and the consensus estimate for December, 2024 decreased significantly. Significant negative changes […]
For its first fiscal quarter (ending September 30), News Corp (NASDAQ: NWSA) has reported a -29% decline in E.P.S. from $0.07 a year ago to $0.05 in the current quarter. This performance was $-0.04 short […]
Hologic Inc (NASDAQ: HOLX) has reported E.P.S. of $0.37 for its fourth fiscal quarter (ending September 30) versus $0.47 for the same period a year ago — a decline of -21%. Relative to the consensus […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research